Herein, a poly(ionic liquid MOF) composite monolithic column was ready through in situ radical polymerization utilizing ionic liquid (1-allyl-3-methylimidazolium hexafluorophosphate) and MOF (derivatized UIO66-2COOH) as copolymer
Antibodies to infliximab (ATI) in serum are related to secondary lack of response (LOR) to infliximab (IFX) remedy in sufferers with inflammatory bowel illness (IBD).